BeardedVol
Not-Well-Known Member
- Joined
- Nov 6, 2012
- Messages
- 14,440
- Likes
- 27,716
Hydroxychloroquine flunks Phase III trial in mild-to-moderate Covid-19 - MedCity NewsActually, YES. 200mg per day. PLAQUINAL. & Zinc. Search that.
Results of the randomized, controlled, open-label Phase III trial, which took place at more than two dozen sites in Brazil, were published in the New England Journal of Medicine on Thursday. The study randomized 667 patients to receive hydroxychloroquine or the drug plus the antibiotic azithromycin on top of standard of care or standard of care alone. When patients were measured on the seven-point ordinal scale of improvement in disease, those in the two hydroxychloroquine groups showed no improvement compared with patients who received standard of care alone. Moreover, those receiving hydroxychloroquine more frequently experienced Qt prolongation and elevation of liver enzymes.